Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias

This publication has 37 references indexed in Scilit:

• Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers
  Pain, 2014
• β-Arrestins: Regulatory Role and Therapeutic Potential in Opioid and Cannabinoid Receptor-Mediated Analgesia
  2013
• Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain
  Journal of Medicinal Chemistry, 2013
• A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine
  The Journal of Pharmacology and Experimental Therapeutics, 2013
• Efficient, highly diastereoselective MS 4 Å-promoted one-pot, three-component synthesis of 2,6-disubstituted-4-tosyloxytetrahydropyrans via Prins cyclization
  Beilstein Journal of Organic Chemistry, 2012
• Opioids and the control of respiration
  British Journal of Anaesthesia, 2008
• Morphine Side Effects in β-Arrestin 2 Knockout Mice
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Mu opioid receptor regulation and opiate responsiveness
  The AAPS Journal, 2005
• Anesthetic Potency and Influence of Morphine and Sevoflurane on Respiration in μ-Opioid Receptor Knockout Mice
  Anesthesiology, 2001
• Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
  Science, 1999